These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36749623)

  • 21. Differential Medication Attitudes to Antihypertensive and Mood Stabilizing Agents in response to an Automated Text-Messaging Adherence Enhancement Intervention.
    Klein P; Aebi ME; Sajatovic M; Depp C; Moore D; Blixen C; Levin JB
    J Behav Cogn Ther; 2020 Apr; 30(1):57-64. PubMed ID: 33409504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study.
    Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F;
    J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication Adherence in Pediatric Patients with Bipolar Disorder: A Systematic Review.
    Sanchez M; Lytle S; Neudecker M; McVoy M
    J Child Adolesc Psychopharmacol; 2021 Mar; 31(2):86-94. PubMed ID: 33465006
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictors of psychotropic medication adherence among HIV+ individuals living with bipolar disorder.
    Casaletto KB; Kwan S; Montoya JL; Obermeit LC; Gouaux B; Poquette A; Heaton RK; Atkinson JH; Moore DJ;
    Int J Psychiatry Med; 2016; 51(1):69-83. PubMed ID: 26681237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review.
    Bessonova L; Ogden K; Doane MJ; O'Sullivan AK; Tohen M
    Clinicoecon Outcomes Res; 2020; 12():481-497. PubMed ID: 32982338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.
    Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen H; Isometsä E
    J Affect Disord; 2014 Feb; 155():110-7. PubMed ID: 24262639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated strategies for the management of poor medication adherence in patients with bipolar disorder.
    McVoy M; Levin JB
    Expert Rev Neurother; 2023 Apr; 23(4):365-376. PubMed ID: 37036814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a difference in subjective experience of cognitive function in patients with unipolar disorder versus bipolar disorder?
    Miskowiak K; Vinberg M; Christensen EM; Kessing LV
    Nord J Psychiatry; 2012 Dec; 66(6):389-95. PubMed ID: 22401272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder.
    Schneck CD; Chang KD; Singh MK; DelBello MP; Miklowitz DJ
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):796-805. PubMed ID: 28731778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Bareis N; Lu J; Kirkwood CK; Kornstein SG; Wu E; Mezuk B
    J Affect Disord; 2018 Oct; 238():147-155. PubMed ID: 29883936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study.
    Depp CA; Lebowitz BD; Patterson TL; Lacro JP; Jeste DV
    Bipolar Disord; 2007 Sep; 9(6):636-45. PubMed ID: 17845279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program.
    Fond G; Tinland A; Boucekine M; Girard V; Loubière S; Auquier P; Boyer L;
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():84-89. PubMed ID: 30153497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient Participation in the Development of a Customized M-Health Intervention to Improve Medication Adherence in Poorly Adherent Individuals with Bipolar Disorder (BD) and Hypertension (HTN).
    Blixen C; Sajatovic M; Moore DJ; Depp C; Cushman C; Cage J; Barboza M; Eskew L; Klein P; Levin JB
    Int J Healthc; 2018; 4(1):25-35. PubMed ID: 30410985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of quality of life in bipolar disorder: A path analytical study.
    Cotrena C; Branco LD; Shansis FM; Fonseca RP
    Psychiatry Res; 2020 Feb; 285():112846. PubMed ID: 32066003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study.
    Driscoll KE; Sit DKY; Moses-Kolko EL; Pinheiro E; Yang A; Ciolino JD; Eng HF; Luther JF; Clark CT; Wisniewski SR; Wisner KL
    Bipolar Disord; 2017 Jun; 19(4):295-304. PubMed ID: 28665044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).
    Barraco A; Rossi A; Nicolò G;
    CNS Neurosci Ther; 2012 Feb; 18(2):110-8. PubMed ID: 21199448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of the BD SX: a brief measure of mood and symptom variability for use with adults with bipolar disorder.
    O'Rourke N; Sixsmith A; King DB; Yaghoubi-Shahir H; Canham SL;
    Int J Bipolar Disord; 2016 Dec; 4(1):8. PubMed ID: 26928123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trajectories of medication adherence in patients with Bipolar Disorder along 2 years-follow-up.
    Consoloni JL; M'Bailara K; Perchec C; Aouizerate B; Aubin V; Azorin JM; Bellivier F; Correard N; Courtet P; Dubertret C; Etain B; Gard S; Haffen E; Leboyer M; Llorca PM; Olié E; Polosan M; Roux P; Schwan R; Samalin L; Belzeaux R;
    J Affect Disord; 2021 Mar; 282():812-819. PubMed ID: 33601722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.
    Moore DJ; Posada C; Parikh M; Arce M; Vaida F; Riggs PK; Gouaux B; Ellis RJ; Letendre SL; Grant I; Atkinson JH;
    AIDS Behav; 2012 Nov; 16(8):2257-66. PubMed ID: 22041931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort.
    Belzeaux R; Correard N; Boyer L; Etain B; Loftus J; Bellivier F; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2013 Dec; 151(3):1009-15. PubMed ID: 24051101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.